Back to Search
Start Over
False-positive pregnancy tests in females of reproductive potential receiving lenalidomide in the United States
- Source :
- Leukemia & Lymphoma. 59:1025-1026
- Publication Year :
- 2017
- Publisher :
- Informa UK Limited, 2017.
-
Abstract
- Lenalidomide is approved in the United States for various indications, including multiple myeloma (MM), myelodysplastic syndrome associated with a deletion 5q cytogenetic abnormality and relapsed, ...
- Subjects :
- Adult
Oncology
Cancer Research
medicine.medical_specialty
Ectromelia
Pregnancy Tests
MEDLINE
Lymphoma, Mantle-Cell
030226 pharmacology & pharmacy
03 medical and health sciences
0302 clinical medicine
Pregnancy
Internal medicine
Cytogenetic Abnormality
Humans
Medicine
False Positive Reactions
030212 general & internal medicine
Lenalidomide
Maternal-Fetal Exchange
Multiple myeloma
Gynecology
business.industry
Abnormalities, Drug-Induced
Hematology
Middle Aged
medicine.disease
United States
Lymphoma
False positive pregnancy tests
Myelodysplastic Syndromes
Reproductive potential
Female
Multiple Myeloma
business
medicine.drug
Subjects
Details
- ISSN :
- 10292403 and 10428194
- Volume :
- 59
- Database :
- OpenAIRE
- Journal :
- Leukemia & Lymphoma
- Accession number :
- edsair.doi.dedup.....7229f9a00c1951e311af788f531a5bf7
- Full Text :
- https://doi.org/10.1080/10428194.2017.1361030